The U.S. Food and Drug Administration (FDA) has approved, under priority review, the use of Benlysta (belimumab)…
Joana Carvalho, PhD
Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Carvalho, PhD
The Lupus Research Alliance (LRA) has funded a series of research projects, ongoing worldwide, aimed at seeking new therapies…
A group of scientists from the University of Pennsylvania may have found part of the reason lupus is…
A frailty index developed by the Systemic Lupus International Collaborating Clinics (SLICC) could be a powerful and meaningful health measure to estimate…
Systemic lupus erythematosus (SLE) patients have a higher risk for certain cancers — including cervical, thyroid, ovarian, and oral…
Defects in the Ets1 gene in T-cells, immune system cells with known links to inflammation, caused the uncontrolled expansion of some…
Researchers from the Feinstein Institute for Medical Research have developed a bioelectronic device that is effective at reducing pain and…
Immugenyx, a subsidiary of Hemogenyx Pharmaceuticals, has partnered with Janssen Research & Development, one of the Janssen…
DN2 B-cells — a subset of immune B-cells that are rare in healthy individuals, but extremely common in patients with…
Black Africans often have distinct variants of systemic lupus erythematosus compared to white patients, but conventional diagnostic tests can’t detect…